Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Fast Company Names HeartFlow One of the World’s Most Innovative Companies

0

HeartFlow Earns a Top Position in Artificial Intelligence for 2019

HeartFlow, Inc., a medical technology company uniquely positioned at the intersection of advanced artificial intelligence (AI) capabilities and healthcare, announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019. The list honors the businesses making the most profound impact on both industry and culture.

Read More: Google India Kicks off Round Two of Its Launchpad Accelerator

HeartFlow is recognized in the Artificial Intelligence category for the HeartFlow Analysis, a noninvasive, cardiac test that leverages deep learning, a form of AI, combined with the efforts of highly trained human analysts to create a personalized 3D model of the heart. It applies advanced algorithms to solve millions of complex equations to assess the impact of blockages on blood flow to the heart, helping physicians visualize the problem and determine the best treatment pathway for each patient. With the HeartFlow Analysis, HeartFlow is driving towards a new standard of care for the diagnosis and treatment of heart disease – the number one killer worldwide according to the Centers for Disease Control.

Read More: Smart Managers Know There’s More to Leading a Team Than Simply Being a Boss

The HeartFlow technology has been demonstrated to significantly reduce unnecessary and invasive diagnostic coronary angiography procedures, which can be associated with bleeding, stroke, major blood vessel damage and other serious complications. By non-invasively identifying which patients do and do not need intervention, clinicians can reduce unnecessary invasive testing, reduce healthcare system costs and improve patient quality of life.1 To date, clinicians have used the HeartFlow Analysis for more than 30,000 patients to aid in the diagnosis of heart disease.

“At HeartFlow, we’re taking the best of cutting-edge technology and applying it to help physicians save lives,” said John H. Stevens, M.D., president and chief executive officer of HeartFlow. “We’ve only just scratched the surface of the tremendous potential of AI in healthcare and we’re eager to bring our innovative approach to diagnosing and treating heart disease to the world.”

Read More: NVIDIA Backs Round-The-Clock Checkout-Free Grocery Shopping Start-Up AiFi

Leave A Reply

Your email address will not be published.